日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Mnes’ LOOKREC Integrates with Smart TOHMAS System
Mnes Co., Ltd. They provide LOOKREC, a cloud platform for managing and…
Mediva Adds Task Management to WellaboSWP Platform
Mediva Inc. and Honest Inc. have added a new function, "Task Management…
Verified Clinical Trials launches in Japan to curb duplicates
Verified Clinical Trials (VCT) is now operating in Japan. They teamed up…
Kaigo Supplement Patents AI System for Dementia Care
Kaigo Supplement Inc., a company that provides business support systems for the…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Crosslog, MeCompany Partner on SCUEL Healthcare Data
Crosslog Inc. is pleased to announce that it has entered into a…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Latest Article
English